Levodopa-Carbidopa Intestinal Gel (LCIG)
S187.3.005
Phase 3 small_molecule completed
Quick answer
Levodopa-Carbidopa Intestinal Gel (LCIG) for Advanced Parkinson's Disease is a Phase 3 program (small_molecule) at AbbVie with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie
- Indication
- Advanced Parkinson's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed